Hinova Pharmaceuticals Inc.
7 clinical trials · Sponsor
◉ Watch Hinova Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH ) (NCT07308548) | Hinova Pharmaceuticals Inc. | 2025-10-11 |
| A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer (NCT06757335) | Hinova Pharmaceuticals Inc. | 2025-01-07 |
| A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients (NCT06155084) | Hinova Pharmaceuticals Inc. | 2023-12-26 |
| A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). (NCT03851640) | Hinova Pharmaceuticals Inc. | 2019-04-12 |
| A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch (NCT03778047) | Hinova Pharmaceuticals Inc. | 2018-02-07 |
| A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics (NCT03776968) | Hinova Pharmaceuticals Inc. | 2017-10-24 |
Track Hinova Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.